First-Ever Multicenter Study of Hypothermic Oxygenated Perfusion (HOPE) with VitaSmart™ in Pediatric Liver Transplants Confirms Safety and Favorable Outcomes

FOR IMMEDIATE RELEASE First-Ever Multicenter Study of Hypothermic Oxygenated Perfusion (HOPE) with VitaSmart™ in Pediatric Liver Transplants Confirms Safety and Favorable Outcomes Groundbreaking: The first multicenter study in any machine perfusion device,

Bridge to Life Receives FDA 510(k) Clearance for Multi-Sourced Belzer UW® and MPS® Solutions with Expanded Labeling for MPS® Across All Abdominal Organs

Bridge to Life Receives FDA 510(k) Clearance for Multi-Sourced Belzer UW® and MPS® Solutions with Expanded Labeling for MPS® Across All Abdominal Organs Duluth, GA – October 7, 2025 – Bridge to